Replies to post #123687 on Biotech Values

[ghmm]

Did they have any leverage? If Pfizer backed out could have they easily re-partnered?

[DewDiligence]

The ~150% premium isn't so impressive when you are starting from a measly ~$15M market cap… if you are starting with a much lower market cap then, all things being equal, the percentage premium should be a lot higher.

I respectfully disagree. Please examine the table entries in #msg-65401590. Do you see evidence that the buyout premium is higher when the deal value is lower and vice-versa?

I don’t see such a pattern. To the contrary, the entries in the table appear to be distributed randomly.